EON the touchless, intelligent body contouring device developed by Dominion Aesthetic Technologies has closed Series B financing, raising a total of $23.7 million. Series B funding will accelerate the manufacturing and commercialization of EON as the leading innovator in the field of aesthetics.
Chief Financial Officer, Gerry Sheridan, Chief Financial Officer, Dominion Aesthetic Technologies, commented: “We appreciate the confidence our investors have shown in the company with our Series B round closing oversubscribed, which will allow us to focus on the manufacturing and commercialization of EON at an exciting and pivotal time in the company’s development.”
Cooper Collins, CEO, Dominion Aesthetic Technologies, stated: “There are very few opportunities to grow a company this rapidly, and this is clearly due to our innovative product and solid network base. None of this would be possible without our world-class investors and our experienced commercialization team.”
EON is an FDA-cleared 1064 nm robotic laser device used for touchless, external non-invasive lipolysis of the abdomen. As no part of the device directly touches the patient, it is unique in its class. There are no disposables or treatment applicators as seen in other body contouring devices. EON’s treatment head combines a laser, which heats adipose tissue to induce apoptosis, with a jet-inspired impingement cooling system that protects the skin and provides patient comfort. The microprocessor-controlled articulated robotic arm delivers consistent applications of laser energy over the designated treatment area. EON delivers superior fat reduction results of the full abdomen in 60 minutes without the need for post-procedure massages.
